Evidence-based complementary oncology. Innovative approaches to optimize standard therapy strategies

In Vivo

Volumn 21, Issue 2, 2007, Pages 423-428

  Beuth, Josef ^a   Schierholz, Joerg Michael ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Medical Department Research and Development   (Germany)

Author keywords

Cancer therapy; Complementary medicine; Evidence based medicine; Proof of efficacy; Review

Indexed keywords

ANTINEOPLASTIC AGENT; CHYMOTRYPSIN; LENTINAN; MINERAL; PAPAIN; PLACEBO; PROTEINASE; SELENIUM; TRACE ELEMENT; TRYPSIN; VISCUM ALBUM EXTRACT; VITAMIN; PEPTIDE HYDROLASE;

ADJUVANT THERAPY; ALTERNATIVE MEDICINE; ANALGESIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APHTHOUS ULCER; APPETITE; BREAST CANCER; CACHEXIA; CANCER; CANCER MORTALITY; CANCER PREVENTION; CLINICAL TRIAL; CYTOTOXICITY; DIARRHEA; DIET SUPPLEMENTATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG SAFETY; DRUG TARGETING; EVIDENCE BASED MEDICINE; HUMAN; HYPERPYREXIA; HYPERTHERMIA; IMMUNOSTIMULATION; INFLAMMATION; LUNG CANCER; MALNUTRITION; MUSCLE EXERCISE; NAUSEA AND VOMITING; NUTRITIONAL SUPPORT; ONCOLOGY; OPTIMAL DRUG DOSE; OVARY CANCER; PROGNOSIS; PSYCHOTHERAPY; PUBLIC HEALTH; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SWEATING; UTERINE CERVIX CANCER; VITAMIN SUPPLEMENTATION; EXERCISE; HYPERTHERMIC THERAPY; NEOPLASM; NUTRITIONAL ASSESSMENT; PHYTOTHERAPY; PSYCHOLOGICAL ASPECT; SOCIAL SUPPORT;

COMPLEMENTARY THERAPIES; EVIDENCE-BASED MEDICINE; EXERCISE; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASMS; NUTRITION ASSESSMENT; PEPTIDE HYDROLASES; PHYTOTHERAPY; SOCIAL SUPPORT; TRACE ELEMENTS; VITAMINS;

EID: 34047221404     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Bailar JC and Gornik HL: Cancer undefeated. N Engl J Med 336: 1569-1574, 1997.
2. Abel U: Chemotherapie fortgeschrittener Karzinome. Hippokrates Verlag, Stuttgart, 1995.
3. Moss RW: Questioning chemotherapy. Equinox Press NY, 1995.
4. de Vita VT, Hellman S and Rosenberg SA: Cancer. Principles and practices of oncology. Lippincott Williams and Wilkins, USA, 6th edition, 2001.
5. Beuth J and Moss RW: Complementary oncology. Adjunctive Methods in the treatment of cancer. Thieme NY, 2005.
6. Unger C and Weis J: Onkologie. Unkonventionelle und supportive Therapiestrategien. Wissenschaftliche Verlagsgesellschaft, 2005.
7. Haunstein KO, Hoeffler D, Lasek R et al: Außerhalb der wissenschaftlichen Medizin stehende Methoden der Arzneitherapie. Dtsch Aerztebl 95: 800-805, 1998.
8. Doll R and Peto R: The causes of cancer. Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66: 1193-1208, 1981.
9. Prasad KN and Cole WC: Cancer and nutrition. IOS Press Amsterdam, Netherlands, 1998.
10. Zuercher G: Tumoren. In: Ernaehrungsmedizin in der Praxis: Aktuelles Handbuch zur Prophylaxe und Therapie ernaehrungsabhaengiger Erkrankungen. Kluthe R (ed.). Spitta Verlag, 2001.
11. Stiefelhagen P: Ernaehrung und Krebs - Was ist gesichert? Deutsche Zeitschrift fuer Onkologie 38: 35-39, 2006.
12. Zuercher G: Krebsdiäten. Forum DKG 4: 49-51, 2006.
13. Landessportbund NRW: Sport in der Krebsnachsorge. Landessportbund NRW, 2005.
14. Holmes MD, Chen WY, Freskanich D et al: Physical activity and survival of breast cancer diagnosis. JAMA 293: 2479-2486, 2005.
15. Meyerhardt JA, Haseltine D, Niedzwiecki D et al: The impact of physical activity on patients with stage III colon cancer. Findings from Intergroup trial CALBG 89803. J Clin Oncol 23: 3534, 2005.
16. Tschuschke V: Psychoonkologie. Schattauer Verlag, 2005.
17. Schulz T, Peters C and Michna H: Bewegungstherapie und Sport in der Krebstherapie und -nachsorge. Deutsche Zeitschrift fuer Onkologie 37: 159-168, 2005.
18. Schuele K: Bewegung und Sport in der Krebsnachsorge. Forum DKG 2: 39-41, 2001.
19. Spiegel D and Classen C: Group therapy for cancer patients. Basic behavorial science. Basic Books Publ USA, 2000.
20. Rehse B: Metaanalytische Untersuchungen zur Lebensqualitaet adjuvant psychoonkologisch betreuter Krebsbetroffener. Shaker Verlag, Aachen, 2001.
21. Büssing A: Biological and pharmaceutical properties of viscum album. In: Mistletoe. The Genus Viscum. Büssing A. (ed.). Harwood academic publishers, pp. 123-182, 2000.
22. Kiene GS, Berrino F, Buessing A et al: Mistletoe in cancer. A systematic review on controlled clinical trials. Europ J Med Res 8: 109-119, 2003
23. Piao BK, Wang XY, Xie GR et al: Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res 24: 303-310, 2004.
24. Semiglasov VF, Stepula VV, Dudor A et al: Quality of life is improved in breast cancer patients by standardised mistletoe extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Res 6: 1519-1530, 2004.
25. Groeber U: Mikronaehrstoffe. Wissenschaftliche Verlagsgesellschaft Stuttgart, 2006.
26. Prasad KN, Cole WC, Kumar B et al: Scientific rationale for using high dose multiple micronutrients as an adjunct to standard and experimental cancer therapies. Am J Coll Nutr 20: 450-463, 2001.
27. Bruns F, Buentzel J, Mucke R et al: Selenium in the treatment of head and neck lymphedema. Med Print Pract 13: 185-190, 2004.
28. Zimmermann T, Leonhardt H, Kersting S et al: Reduction of postoperative lymphedema after oral tumor surgery with sodium selenite. Biol Trace Elem Res 106: 193-203, 2005.
29. Kasseroller RG and Schrauzer GN: Treatment of secondary lymphedema of the arm with physical decongestive therapy and sodium selenite. Am J Ther 7: 273-279, 2000.
30. Hehr T, Bamberg M and Rodemann HP: Praeklinische und klinische Relevanz der radioprotektiven Wirkung von Natriumselenit. InFo Onkol S2: 25-29, 1999.
31. Roth T and Fiebig HH: Cytotoxic profile of sodium selenite (Selenase) and sodium selenite in combination with clinically used chemotherapeutic agents in human tumor models. InFo Onkol S2: 30-39, 1999.
32. Popiela T, Kulig J, Hanisch J et al: Influence of complementary treatment with oral enzymes on patients with colorectal cancers: an epidemiological retrolective cohort study. Caner Chemother Pharmacol S47: 55-63, 2001.
33. Sakalova H, Bock PR, Dedik L et al: Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma. Cancer Chemother Pharmacol S47: 38-41, 2001.
34. Beuth J, Ost B, Pakdaman A et al: Impact of complementary enzyme application on the postoperative treatment results of breast cancer patients. Results of an epidemiological multicenter cohort study. Cancer Chemother Pharmacol S47: 38-44, 2001.
35. Wust P and Hildebrand D: ESHO. 23 Congress of the European Society of Hyperthermia in Oncology. Forum DKG 4: 49-51, 2006.
36. Beuth J: Grundlagen der Komplementäronkologie. Hippokrates Verlag Stuttgart, 2002.
37. Kuttan G and Kuttan R: Immunomodulatory activity of a peptide isolated from Viscum album extract. Immunol Investig 21: 285-296, 1992.
38. Kienle G and Kiehe H: Dic Mistel der Onkologie, Schattaner Verlag Stuttgart, 2003.